Board of Directors - NeurOptics
neuroptics board of directors
pupillometer, pupillometry, critical care, critical care nursing, ophthalmology, optometry, emergency medicine, neurosurgery
page-template,page-template-full_width,page-template-full_width-php,page,page-id-16650,bridge-core-2.8.4,vcwb,qode-page-transition-enabled,ajax_fade,page_not_loaded,,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-26.8,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

Board of Directors

Board of Directors

Kamran Siminou,  Executive Chairman – Founder, NeurOptics

Kamran Siminou experience spans 20 years in Research and Development, Marketing and Business Development for leading healthcare companies such as General Electric and Baxter International. Kamran is named as an Inventor in over 20 patents as it relates to infrared pupillometry and its application in neurocritical care and ophthalmology. Kamran holds a Bachelor of Science in Electrical Engineering from University of Central Florida, an MBA from University of California-Irvine, and the Stanford Executive Program (SEP) from Stanford University.

William Worthen,  President and Chief Executive Officer, NeurOptics

Bill Worthen is the President and CEO of NeurOptics and brings more than 30 years of experience in the medical device space. Prior to joining NeurOptics in 2013, Bill served as President and CEO of several medical device companies including Silk Road Medical, Alsius Corporation (acquired in 2009 by Zoll Medical Corporation) and Neuro Navigational Corporation. He also held various sales and marketing management positions at American Hospital Supply Corporation (Edwards Laboratories), Trimedyne and InterTherapy. Bill received a Bachelor of Science in Marketing from San Diego State University.

Robert Mellen,  Venture Partner – Aphelion Capital

Bob Mellen has spent over 25 years in the medical device industry in marketing, general management and senior business development roles. After gaining sales, marketing and start-up experience at Ohmeda and Stericycle, Bob joined C. R. Bard in 1993, where he led the marketing teams at the Gynecology/Radiology and Access Systems Divisions. Bob spent the following five years leading the Peripheral Technologies/Peripheral Vascular Division as General Manager and President, followed by 10 years as Bard’s Corporate Vice President, Strategic Planning and Business Development. Bob earned a BA in Biology from Harvard College and an MBA from Harvard Business School.